Pharma company Cadila on Thursday announced a 40.56% jump in the consolidated net profit to ₹390.91 crore for the July-September quarter. The standalone total income of the pharma multinational has risen from  ₹1,396.6 crore for the same quarter last year to  ₹1,976.45 crore this year, the company said in a BSE filing.  
